Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: IMO, re-validated 148, is a catch all for the other 6 MMP patents and the 7 new

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

IMO, re-validated 148, is a catch all for the other 6 MMP patents and the 7 new

Mark4321

Sep 09, 2008 03:02PM

dys1

Rank: Treasurer [?]

Points: 3817 [?]

Votes: 62 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: IMO, re-validated 148, is a catch all for the other 6 MMP patents and the 7 new

in response to

IMO, re-validated 148, is a catch all for the other 6 MMP patents and the 7 new

Mark4321

posted on Sep 09, 2008 05:24PM

When do you think we'd PR any re-cert? Before or after publishing. Your posts (along with others) help who may be somewhat USTPO challenged in following what's going on......

3 Recommendations

Re: IMO, re-validated 148, is a catch all for the other 6 MMP patents and the 7 new

Mark4321

Sep 10, 2008 01:46AM

Re: IMO, re-validated 148, is a catch all for the other 6 MMP patents and the 7 new

on2u

Sep 10, 2008 02:09AM

Re: IMO, re-validated 148, is a catch all for the other 6 MMP patents and the 7 new

dys1

Sep 10, 2008 04:21AM